GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (FRA:AN6) » Definitions » Cash Receipts from Operating Activities

AnaptysBio (FRA:AN6) Cash Receipts from Operating Activities


View and export this data going back to 2017. Start your Free Trial

What is AnaptysBio Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


AnaptysBio (FRA:AN6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (FRA:AN6) » Definitions » Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonists. The entity generates revenue from collaborative research and development arrangements.